A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

NCT05583617 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cevostamab
DRUG: Lenalidomide
DRUG: Tocilizumab
DRUG: Iberdomide
DRUG: Dexamethasone

Sponsor

Hoffmann-La Roche